These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16048253)

  • 1. Lessons from basic research for PD treatment.
    Jörres A; Witowski J
    Perit Dial Int; 2005 Feb; 25 Suppl 3():S35-8. PubMed ID: 16048253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of peritoneal dialysis solutions on the peritoneal membrane: clinical consequences.
    Witowski J; Jörres A
    Perit Dial Int; 2005 Feb; 25 Suppl 3():S31-4. PubMed ID: 16048252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin and the peritoneal membrane.
    Margetts P
    Perit Dial Int; 2009; 29(1):16-9. PubMed ID: 19164247
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic exposure of mouse peritoneum to peritoneal dialysis fluid: structural and functional alterations of the peritoneal membrane.
    González-Mateo GT; Loureiro J; Jiménez-Hefferman JA; Bajo MA; Selgas R; López-Cabrera M; Aroeira LS
    Perit Dial Int; 2009; 29(2):227-30. PubMed ID: 19293361
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of various dialysis solutions on peritoneal membrane viability.
    Krediet RT; Zweers MM; Ho-dac-Pannekeet MM; van der Wal AC; Smit W; Douma CE; Mateijsen MA; Struijk DG
    Perit Dial Int; 1999; 19 Suppl 2():S257-66. PubMed ID: 10406529
    [No Abstract]   [Full Text] [Related]  

  • 6. [Function of the peritoneum in hyperglycemic conditions].
    Czyzewska K
    Postepy Hig Med Dosw; 1994; 48(3):291-307. PubMed ID: 7971603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there such a thing as biocompatible peritoneal dialysis fluid?
    Schmitt CP; Aufricht C
    Pediatr Nephrol; 2017 Oct; 32(10):1835-1843. PubMed ID: 27722783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How can genetic advances impact on experimental models of encapsulating peritoneal sclerosis?
    Summers AM; Hoff CM; Topley N
    Perit Dial Int; 2008 Nov; 28 Suppl 5():S16-20. PubMed ID: 19008534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolved molecular hydrogen (H
    Nakayama M; Zhu WJ; Watanabe K; Gibo A; Sherif AM; Kabayama S; Ito S
    BMC Nephrol; 2017 Oct; 18(1):327. PubMed ID: 29089029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second European peritoneal dialysis meeting, Gent, 11-12 March 1996.
    Vanholder R; Lameire N
    Nephrol Dial Transplant; 1996 Oct; 11(10):2103-6. PubMed ID: 8918738
    [No Abstract]   [Full Text] [Related]  

  • 11. Studying the effects of new peritoneal dialysis solutions on the peritoneum.
    Chan TM; Yung S
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S87-93. PubMed ID: 17556337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of icodextrin on the peritoneal membrane. An inaccurate comment.
    Gotloib L
    Nephrol Dial Transplant; 2010 Sep; 25(9):3125-6; author reply 3126. PubMed ID: 20576721
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute effects of peritoneal dialysis solutions in the mesenteric microcirculation.
    Frajewicki V; Brod V; Kushnir D; Kohan R; Bitterman H
    Transl Res; 2009 May; 153(5):249-56. PubMed ID: 19375686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical indices of in vivo biocompatibility: the role of ex vivo cell function studies and effluent markers in peritoneal dialysis patients.
    Mackenzie R; Holmes CJ; Jones S; Williams JD; Topley N
    Kidney Int Suppl; 2003 Dec; (88):S84-93. PubMed ID: 14870881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-induced mesothelial cell senescence and peritoneal neoangiogenesis and fibrosis.
    Witowski J; Ksiazek K; Jörres A
    Perit Dial Int; 2008 Nov; 28 Suppl 5():S34-7. PubMed ID: 19008538
    [No Abstract]   [Full Text] [Related]  

  • 16. The peritoneum: from histological studies to mesothelial transplant through animal experimentation.
    Di Paolo N; Nicolai GA; Garosi G
    Perit Dial Int; 2008 Nov; 28 Suppl 5():S5-9. PubMed ID: 19008542
    [No Abstract]   [Full Text] [Related]  

  • 17. Multidirectional approach to study peritoneal dialysis fluid biocompatibility in a chronic peritoneal dialysis model in the rat.
    Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Pawlaczyk K; Kuzlan-Pawlaczyk M; Filas V; Breborowicz A; Oreopoulos DG
    Nephrol Dial Transplant; 2001 Mar; 16(3):655-6. PubMed ID: 11239060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term peritoneal dialysis-impact of peritoneal membrane changes and newer solutions.
    Krediet RT
    Int J Artif Organs; 1998 Aug; 21(8):437-9. PubMed ID: 9803343
    [No Abstract]   [Full Text] [Related]  

  • 19. Future of icodextrin as an osmotic agent in peritoneal dialysis.
    Pecoits-Filho R; Mujais S; Lindholm B
    Kidney Int Suppl; 2002 Oct; (81):S80-7. PubMed ID: 12230485
    [No Abstract]   [Full Text] [Related]  

  • 20. Will peritoneal dialysis be left behind?
    Prichard S
    Semin Dial; 2005; 18(3):167-70. PubMed ID: 15934955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.